Warnyta Minnaard

Warnyta Minnaard

If the practitioner doesn’t know where the primary tumor is located, they cannot offer a targeted treatment plan, and nor can they give the patient an estimate of their life expectancy.

Back to news

More news

Erasmus MC Cancer Institute introduces comprehensive DNA testing for CUP cancer patients in EMBRAZE region

Erasmus MC Cancer Institute introduces comprehensive DNA testing for CUP cancer patients in EMBRAZE region

01-08-2021

The Erasmus MC Cancer Institute has started using comprehensive DNA testing for carcinoma of unknown primary (CUP) cancer patients in …

Measuring the effects of radiotherapy on cancer may open up avenues for treatment

Measuring the effects of radiotherapy on cancer may open up avenues for treatment

21-05-2021

Radiotherapy works by damaging the DNA of cancer cells. It’s an effective strategy overall, but many cancers have subsets of …

Collaboration between Hartwig and CKB makes both parties stronger 

Collaboration between Hartwig and CKB makes both parties stronger 

13-06-2023

Hartwig Medical Foundation has worked with The Jackson Laboratory (JAX) Clinical Knowledgebase (CKB) team since 2020, to the benefit of …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl